Table 1.
Characteristic of the patients
| Characteristics | n =30 | ||
| Etiology (NBNC:B:C) | 10:10:10 | Choline esterase (IU/L) | 262.80 ± 69.34 |
| Background (N:CH:LC) | 10:10:10 | Pre-ALB (mg/dL) | 21.92 ± 7.01 |
| Sex (M:F) | 22:8 | RBP (mg/dL) | 3.19 ± 1.39 |
| Age (yr) | 65.4 ± 10.3 | LCAT (U) | 100.66 ± 25.78 |
| BMI | 24.3 ± 3.1 | Apo-A1 (mg/dL) | 136.73 ± 32.43 |
| ALB (mg/dL) | 4.03 ± 0.60 | ICGR15 (%) | 12.86 ± 6.44 |
| Total Bilirubin (mg/dL) | 0.81 ± 0.28 | Fibrotic area (%) | 15.32 ± 9.69 |
| PT (%) | 98.83 ± 16.85 | APRI | 0.69 ± 0.46 |
| PT-INR | 1.01 ± 0.16 | FibroScan (kPa) | 15.47 ± 13.02 |
| AST (IU/L) | 41.63 ± 21.56 | Hyaluronate (ng/mL) | 120.50 ± 87.71 |
| ALT (IU/L) | 37.03 ± 21.58 | Type IV collagen | 6.85 ± 5.11 |
| Platelet count (104/μL) | 16.14 ± 4.57 | HGF (ng/dL) | 0.30 ± 0.09 |
| ZTT (K-U) | 13.57 ± 9.96 | ||
BMI: Body mass index; ALB: Albumin; PT: Prothrombin time; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ZTT: Zinc turbidity test; TTT: Thymol turbidity test; GGT: Gamma glutamyl transpeptidase; APRI: AST-to platelet ratio index; HGF: Hepatocyte growth factor; RBP: Retinol-binding protein; LCAT: Lecithin-cholesterol acyltransferase; Apo: Apolipoprotein; ICG: Indocyanine.